Innovita Biological Technology Co., Ltd. (SHA:688253)
China flag China · Delayed Price · Currency is CNY
32.54
+1.68 (5.44%)
At close: May 8, 2025, 2:57 PM CST
-21.59%
Market Cap 4.35B
Revenue (ttm) 546.74M
Net Income (ttm) 196.06M
Shares Out 136.46M
EPS (ttm) 1.44
PE Ratio 22.14
Forward PE 16.59
Dividend 0.56 (1.72%)
Ex-Dividend Date n/a
Volume 4,139,047
Average Volume 2,590,064
Open 30.80
Previous Close 30.86
Day's Range 30.72 - 32.79
52-Week Range 27.56 - 52.69
Beta 1.14
RSI 51.27
Earnings Date Apr 26, 2025

About SHA:688253

Innovita Biological Technology Co., Ltd. engages in the research and development, manufacturing, marketing, and sales of POCT rapid diagnostic products. The company offers pathogen detection and joint detection of multiple pathogen; emergency outpatient testing; coronavirus testing; respiratory infections solutions; pregnancy test; hepatitis virus testing ; and enterovirus testing . The company was founded in 2006 and is based in Beijing, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 404
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688253
Full Company Profile

Financial Performance

In 2024, SHA:688253's revenue was 621.39 million, an increase of 29.99% compared to the previous year's 478.02 million. Earnings were 246.86 million, an increase of 41.92%.

Financial Statements

News

There is no news available yet.